ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1230

Comparative Study of Frax® Score in Ecuadorian Population

Genessis Maldonado1, Carlos Paredes1, Roberto Guerrero1, Maricarmen Mieles1, Maria Jose Intriago1, O Messina2 and Carlos Ríos3, 1Universidad Espiritu Santo, Guayaquil, Ecuador, 2Hospital Argerich, Buenos Aires, Argentina, 3Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fracture risk and osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis is a systemic skeletal disease characterized by a decrease in bone mineral density with alterations in bone microarchitecture and an increased risk of fracture. The World Health Organization asserts that it is a major public health problem and increases morbidity and mortality in elderly patients. The FRAX® score is a tool that estimates the risk of fracture at 10 years. It was adapted to the Ecuadorian population in 2009. The purpose of this study was to identify the risk of fracture of the Ecuadorian population using the FRAX® Ecuador calculator and compare the results with FRAX® Colombia, Brazil and the United States (Hispanics).

Methods: A retrospective study that included the Ecuadorian population between 40-90 years old, who underwent bone densitometry between 2013-2015, and whose risk of fracture was assessed with FRAX® Ecuador, Colombia, Brazil and the United States (Hispanics). The DXA values considered were: Osteopenia: T Score -1.0 -2.5 and Osteoporosis: T Score ≥2.5.

Results: We analyzed 1154 patients with a mean age of 61.39 [SD 11.07] (26-97). The predominant gender was female with 88.6% (1022) versus 11.4% (132) male. The mean age of menopause was 45.81 [SD 5.5]. The diagnoses according to bone densitometry were: 18.8% (217) normal, 32.3% (373) osteopenia and 48.9% (564) osteoporosis. The risk of major osteoporotic fracture of the population using FRAX® Ecuador was 1.5% (0.3-27%) and hip 0.5% (0-22%). For FRAX Colombia: 3.0% (0.2-40%) for major osteoporotic fracture and 0.8% (0-34%) for hip fracture. With FRAX® Brazil, 4.2% (1.2-56) was obtained for major osteoporotic fracture and 1.3% (0-49%) for a hip. Finally, FRAX® USA (Hispanic) had a risk of 5.1% (0.7-59%) for major osteoporotic fracture and 1.2% (0-50%) for hip fracture.

Conclusion: The risk of fracture for the Ecuadorian population according to the FRAX® Ecuador calculator was 1.5% for major osteoporotic fracture and 0.5% for hip fracture. Surprisingly, this population presents a low risk of fracture using the calculator of this country, in comparison to the scores obtained using the FRAX® of Colombia, Brazil and the United States (Hispanic). This may indicate that the risk of fracture may be underestimated with FRAX® Ecuador, although more specific studies are needed.


Disclosure: G. Maldonado, None; C. Paredes, None; R. Guerrero, None; M. Mieles, None; M. J. Intriago, None; O. Messina, None; C. Ríos, None.

To cite this abstract in AMA style:

Maldonado G, Paredes C, Guerrero R, Mieles M, Intriago MJ, Messina O, Ríos C. Comparative Study of Frax® Score in Ecuadorian Population [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/comparative-study-of-frax-score-in-ecuadorian-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-study-of-frax-score-in-ecuadorian-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology